Other Events · Nov 3, 2026

Stockholders approve $750K share increase to the 2023 Stock Plan and grant reverse split authority

AMIXAutonomix Medical, Inc.

Autonomix Medical stockholders approved amendments to the 2023 Stock Plan, increasing authorized shares by 750,000 to a total of 750,353. The vote also granted the Board authority to execute a reverse stock split at a ratio between 1-for-2 and 1-for-25 within one year. Six directors were elected and auditor ratification passed. Autonomix Medical develops medical devices for gastrointestinal diagnostics.